• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ECTRIMS 2017 DAILY REPORT – THURSDAY EDITION

October 26, 2017  

MS Sequencing Part 7: What is a rational approach?

October 17, 2017  

Cladribine: intermittent immunosuppression in MS

September 21, 2017  

New findings on gut microbiome and MS

September 13, 2017  

The return of cladribine in RRMS

August 23, 2017  

Health Canada approves Ocrevus for RRMS

August 16, 2017  

MS Sequencing: Part 6: Safety considerations when sequencing

July 26, 2017  

Delays in diagnosis, treatment: MS patient survey

July 19, 2017  

MS Sequencing: Part 5 – Strategies for optimizing response

June 29, 2017  

Progressive MS studies

May 19, 2017  
Previous
23
24
25
26
27
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions